New evidenced-based guidelines from the American College of Chest Physicians (ACCP) recommend against the use of low-dose computed tomography (LDCT) for the general screening of lung cancer.
Young women at risk of having a pulmonary embolism?a potential life-threatening blockage in a lung artery?should first undergo a ventilation/perfusion lung scan (V/Q scan) rather than a CT (computed tomography) angiogram, conclude authors in a paper published in the September Journal of Nuclear Medicine.
Combining radiation therapy with a drug that helps destroy blood vessels nourishing malignant tumors has been shown in mice to be significantly more effective in treating lung cancer than either approach alone, researchers at UT Southwestern Medical Center have found.
A new technique could pave the way toward screening people at risk for lung cancer for the genetic changes that may foreshadow malignancies, researchers from the University of Colorado say.
Avastin (bevacizumab), Roche’s innovative anti-cancer drug, was approved today in Europe for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), in combination with platinum-based chemotherapy.
Prophylactic cranial irradiation after chemotherapy significantly reduces the risk of brain metastasis and doubles one-year survival in small-cell lung cancer, according to the results of the multicenter phase III randomized EORTC trial 08993-22993, published in the New England Journal of Medicine today.
Cancer causing mutations occur in our bodies every day ? but luckily, we have specific genes that recognize these malignant events and keep cells from growing out of control. Only a few of these genes ? called tumor suppressors ? are currently known.
Lung cancer patients may not need to wait till their radiation treatment is over to know if it worked. A PET scan several weeks after starting radiation treatment for lung cancer can indicate whether the tumor will respond to the treatment, according to a new study by researchers at the University of Michigan Comprehensive Cancer Center.
Combining pre-operative chemotherapy and surgery increases the average chance of survival at five years by approximately 6 percent compared with surgery alone.
A new study confirms that treatment of early stage lung cancer should not be delayed.